Symposium 13
From the bench to the bedside: multiscale strategies to overcome neurodegenerative dementia.

[JSY13-2] Development of therapeutics for neurodegenerative diseases and dementia using ENA-modified oligonucleotides: Disease-modifying therapies for tauopathies and amyotrophic lateral sclerosis (ALS)

*Shinsuke Ishigaki¹ (1. Molecular Neuroscience Research Center, Shiga University of Medical Science )